HIF-1α and locally advanced breast cancer

Breast Journal

Volumn 16, Issue 5, 2010, Pages 569-570

  Marana, Heitor R C ^a,b   Tiezze, Daniel G ^a   De Andrade, Jurandyr M ^a   Da Silva, Joao S ^b  

^a Obstetrics Breast Disease Division   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN C; VASCULOTROPIN D;

ADVANCED CANCER; ANGIOGENESIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; HUMAN; LETTER; LYMPH NODE METASTASIS; PROGNOSIS;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT;

EID: 77956837688     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.00969.x     Document Type: Letter

References (7)

1. Semenza GL. HIF-1 and human disease: One highly involved factor. Genes Dev 2000;14:1983-91.
2. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001;49:507-21.
3. Schindl M, Schoppmann SF, Samonigg H, et al. Overexpression of hypoxia-inducible factor 1a is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002;8:1831-7.
4. Bos R, Zhong H, Hanrahan CF, et al. Levels of hypoxiainducible factor-1alpha during breast carcinogenesis. J Natl Cancer Inst 2001;93:309-314.
5. Schwartzberg LS, Birch R, Hazelton B, et al. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. J Hematother Winter 1992;1:317-27.
6. Schindl M, Schoppmann SF, Samonigg H, et al. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002;8:1831-7.
7. Bos R, van Der Groep P, Greijer AE, et al. Levels of hypoxiainducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003;97:1573- 81.